This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Vincent Meininger: Innovator in Neurological Treatments
Introduction
Vincent Meininger is a notable inventor based in Paris, France. He has made significant contributions to the field of neurology, particularly in the treatment of spasticity. With a total of 2 patents to his name, Meininger is recognized for his innovative approaches to addressing neurological disorders.
Latest Patents
Meininger's latest patents focus on the use of nicergoline in the treatment of spasticity. The first patent concerns the application of nicergoline for treating pyramidal spasticity associated with neurological diseases that involve a pathology of the cerebrospinal tract. The second patent reiterates this innovative use of nicergoline, emphasizing its potential benefits in managing spasticity.
Career Highlights
Vincent Meininger is currently associated with Aventis Pharma S.A., where he continues to develop and refine his ideas in the pharmaceutical industry. His work has been instrumental in advancing treatment options for patients suffering from neurological conditions.
Collaborations
Meininger collaborates with Michel Dib, a fellow innovator in the field. Their partnership has fostered a productive environment for research and development, leading to advancements in treatment methodologies.
Conclusion
Vincent Meininger stands out as a key figure in the realm of neurological treatment innovations. His work with nicergoline showcases his commitment to improving patient outcomes in the field of neurology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile